Institute for Clinical Research Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2003
NCT00210301
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Institute for Clinical Research

Active Ingredients

Drugs in Phase 3 Trials (1)

favipiravir (1 trial)

Drugs in Other Trials (1)

modafinil (provigil) (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2